CAM
Cormorant Asset Management’s Monte Rosa Therapeutics GLUE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-2,893,717
| Closed | -$22.5M | – | 68 |
|
|
2023
Q1 | $22.5M | Hold |
2,893,717
| – | – | 1.48% | 18 |
|
|
2022
Q4 | $22M | Sell |
2,893,717
-100,000
| -3% | -$761K | 1.47% | 23 |
|
|
2022
Q3 | $24.5M | Hold |
2,993,717
| – | – | 1.71% | 21 |
|
|
2022
Q2 | $28.9M | Sell |
2,993,717
-8,482
| -0.3% | -$82K | 2.19% | 13 |
|
|
2022
Q1 | $42.1M | Hold |
3,002,199
| – | – | 3.23% | 9 |
|
|
2021
Q4 | $61.3M | Sell |
3,002,199
-100,000
| -3% | -$2.04M | 3.65% | 6 |
|
|
2021
Q3 | $68M | Sell |
3,102,199
-91,774
| -3% | -$2.01M | 2.76% | 10 |
|
|
2021
Q2 | $69.6M | Buy |
+3,193,973
| New | +$69.6M | 2.36% | 9 |
|